You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bevacizumab refractory

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Glioblastoma Trial in Zhengzhou (Tislelizumab plus Bevacizumab)

Recruiting
  • Recurrent Glioblastoma
  • Tislelizumab plus Bevacizumab
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Sep 11, 2022

Trifluridine/Tipiracil Plus Bevacizumab Versus

Completed
  • Metastatic Colorectal Adenocarcinoma
  • Changsha, Hunan, China
    Hunan Cancer hospital
May 11, 2023

Metastatic Colorectal Cancer Trial in Nanjing (Envafolimab, Trifluridine/Tipiracil, Bevacizumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Sep 24, 2023

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Completed
Has Results
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +8 more
  • Bevacizumab
  • Irinotecan Sucrosofate
  • Chicago, Illinois
    Northwestern University
Dec 21, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)

Not yet recruiting
  • Glioblastoma Multiforme
  • +4 more
  • SIACI of cetuximab and bevacizumab
  • Miami, Florida
    Jackson Memorial Hospital
Jul 14, 2023

Colorectal Cancer Trial (all trans Retinoic Acid, Atezolizumab, Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • all trans Retinoic Acid
  • +2 more
  • (no location specified)
Aug 11, 2023

Metastatic Colorectal Cancer Trial (CA102N, TAS-102, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Sep 8, 2023

Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer Trial in Orlando, Albuquerque

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • olvimulogene nanivacirepvec
  • +3 more
  • Orlando, Florida
    AdventHealth Cancer Institute
Sep 1, 2022

Hepatocellular Carcinoma Trial in Vienna (FMT combined with Atezolizumab plus Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • FMT combined with Atezolizumab plus Bevacizumab
  • Vienna, Austria
    Medical University of Vienna
Feb 19, 2023

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New Haven, Baltimore (Ixabepilone,

Active, not recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • New Haven, Connecticut
  • +1 more
Jan 11, 2023

Multiple Myeloma Trial in Hackensack (Bortezomib)

Terminated
Has Results
  • Multiple Myeloma
  • Hackensack, New Jersey
    The Cancer Center at Hackensack University Medical Center
Jun 24, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab)

Recruiting
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • New York, New York
    Lenox Hill Brain Tumor Center
Nov 10, 2022

Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)

Recruiting
  • Refractory Solid Tumor
  • +4 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 4, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Active, not recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +7 more
  • Anetumab Ravtansine
  • +2 more
  • Orange, California
  • +22 more
Oct 22, 2022

Hepatocellular Carcinoma Trial in Berlin, Hannover (Pembrolizumab, Lenvatinib Capsules)

Recruiting
  • Hepatocellular Carcinoma
  • Berlin, Germany
  • +1 more
May 12, 2022

Called STAR-T to Learn More About Sequential Treatment With

Not yet recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • Regorafenib (BAY73-4506, Stivarga®)
  • +2 more
  • Whippany, New Jersey
    Many locations
Apr 21, 2023

Refractory Metastatic Colorectal Cancer, pMMR, MSS Trial in United States (RP2, RP3, atezolizumab)

Not yet recruiting
  • Refractory Metastatic Colorectal Cancer
  • +2 more
  • RP2
  • +3 more
  • Los Angeles, California
  • +5 more
Feb 24, 2023

Glioblastoma, Glioma, Gliosarcoma Trial in United States (Bevacizumab, TTFields Therapy)

Terminated
Has Results
  • Glioblastoma
  • +2 more
  • La Jolla, California
  • +10 more
May 12, 2021

Gestational Trophoblastic Neoplasia Trial in Hangzhou (PD-1 inhibitor, bevacizumab)

Recruiting
  • Gestational Trophoblastic Neoplasia
  • PD-1 inhibitor， bevacizumab
  • Hangzhou, Zhejiang, China
    Women's Hospital School of Medicine Zhejiang University
Jun 2, 2022

Metastatic Colorectal Carcinoma, Recurrent Colorectal Carcinoma, Refractory Colorectal Carcinoma Trial in United States (drug,

Active, not recruiting
Has Results
  • Metastatic Colorectal Carcinoma
  • +5 more
  • Phoenix, Arizona
  • +9 more
Jan 5, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab and Carboplatin)

Suspended
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Bevacizumab and Carboplatin
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 27, 2021

Ovarian Cancer, Peritoneal Carcinomatosis, Fallopian Tube Cancer Trial in Newport Beach, Orlando (GL-ONC1 alone, or in

Completed
  • Ovarian Cancer
  • +2 more
  • GL-ONC1 alone, or in combination with chemotherapy with or without bevacizumab
  • Newport Beach, California
  • +1 more
Jan 3, 2023

HPV-Related Cervical Carcinoma, HPV-Related Malignancy, Cervical Cancer Trial (VB10.16, Atezolizumab Injection [Tecentriq],

Not yet recruiting
  • HPV-Related Cervical Carcinoma
  • +2 more
  • VB10.16
  • +2 more
  • (no location specified)
Oct 24, 2023

Intracranial Meningioma Trial in United States (Everolimus, Bevacizumab)

Terminated
Has Results
  • Intracranial Meningioma
  • Orlando, Florida
  • +6 more
Nov 8, 2021

Neuroblastoma Trial in Worldwide (Bevacizumab, Temozolomide, Irinotecan)

Active, not recruiting
  • Neuroblastoma
  • Vienna, Austria
  • +9 more
Feb 14, 2022